Anti--enolase Antibodies in Serum from Pediatric Patients
Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights
Figure 1
Levels of anti--enolase antibodies ((a) : IgG; (b) : IgA) in patients with juvenile idiopathic arthritis (JIA), celiac disease (CD), Crohn’s disease (CrD), hereditary periodic fevers (HPF), PFAPA syndrome (PFAPA), and vasculitis (V) and healthy controls (HC). Results are expressed as arbitrary units per mL (AU/mL). Cut-off values are indicated with a dashed line. Patients’ antibody levels are compared to healthy control by t-test ( = P < 0,001, = P < 0,05).
